UBS Group’s BIO-key International BKYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-556
| Closed | -$2.95K | – | 10462 |
|
|
2026
Q1 | $2.95K | Sell |
556
-972
| -64% | -$6.05K | ﹤0.01% | 9173 |
|
|
2025
Q4 | $8.23K | Buy |
1,528
+1,386
| +976% | +$10.6K | ﹤0.01% | 8383 |
|
|
2025
Q3 | $1.02K | Sell |
142
-1,273
| -90% | -$9.93K | ﹤0.01% | 9455 |
|
|
2025
Q2 | $11.6K | Buy |
+1,415
| New | +$11.2K | ﹤0.01% | 8778 |
|
|
2024
Q4 | – | Sell |
-631
| Closed | -$6.05K | – | 9937 |
|
|
2024
Q3 | $6.05K | Buy |
631
+386
| +158% | +$5.55K | ﹤0.01% | 7999 |
|
|
2024
Q2 | $4.01K | Buy |
245
+201
| +457% | +$3.48K | ﹤0.01% | 8139 |
|
|
2024
Q1 | $926 | Buy |
+44
| New | +$890 | ﹤0.01% | 8302 |
|
|
2023
Q4 | – | Hold |
0
| – | -$8 | – | 9323 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9238 |
|
|
2023
Q2 | – | Sell |
-4
| Closed | -$532 | – | 8727 |
|
|
2023
Q1 | $473 | Sell |
4
-105
| -96% | -$14.5K | ﹤0.01% | 9019 |
|
|
2022
Q4 | $11.6K | Buy |
109
+84
| +336% | +$18.3K | ﹤0.01% | 8382 |
|
|
2022
Q3 | $7K | Buy |
25
+13
| +108% | +$4.06K | ﹤0.01% | 8848 |
|
|
2022
Q2 | $4K | Sell |
12
-13
| -52% | -$4.61K | ﹤0.01% | 9040 |
|
|
2022
Q1 | $11K | Buy |
25
+20
| +400% | +$8.08K | ﹤0.01% | 8284 |
|
|
2021
Q4 | $2K | Buy |
+5
| New | +$2.52K | ﹤0.01% | 9780 |
|
|
2021
Q3 | – | Sell |
-21
| Closed | -$12.4K | – | 9543 |
|
|
2021
Q2 | $14K | Buy |
+21
| New | +$13.8K | ﹤0.01% | 7697 |
|
|
2020
Q4 | – | Sell |
-20
| Closed | -$12K | – | 8387 |
|
|
2020
Q3 | $12K | Buy |
+20
| New | +$18.9K | ﹤0.01% | 6688 |
|
|
2020
Q1 | – | Sell |
-1
| Closed | -$1K | – | 7963 |
|
|
2019
Q4 | $1K | Sell |
1
-1
| -50% | -$816 | ﹤0.01% | 7920 |
|
|
2019
Q3 | $1K | Sell |
2
-4
| -67% | -$5.47K | ﹤0.01% | 7814 |
|
|
2019
Q2 | $11K | Buy |
6
+3
| +100% | +$5.19K | ﹤0.01% | 6998 |
|
|
2019
Q1 | $7K | Buy |
3
+1
| +50% | +$1.66K | ﹤0.01% | 6993 |
|
|
2018
Q4 | $3K | Buy |
+2
| New | +$3.55K | ﹤0.01% | 7704 |
|
|
2018
Q3 | – | Sell |
-1
| Closed | -$2.77K | – | 7976 |
|
|
2018
Q2 | $5K | Buy |
+1
| New | +$3.3K | ﹤0.01% | 7457 |
|
UBS Group's BKYI Position: Q2 2026 in Review
UBS Group sold out of BIO-key International (BKYI) in Q2 2026, closing a stake of 556 shares — an estimated $2.95K sold.
UBS Group first reported a position in BKYI in Q2 2018 and held it in 21 quarters. The position peaked at $14K in Q2 2021. 0 funds tracked by Wall St. Rank hold BKYI as of Q2 2026.
- UBS Group reported no remaining BIO-key International position as of Q2 2026 after selling out during the quarter.
- UBS Group sold 556 BIO-key International shares in Q2 2026, an estimated $2.95K.
- UBS Group first reported a position in BIO-key International in Q2 2018 and held it in 21 quarters.
- UBS Group's BIO-key International position peaked at $14K in Q2 2021.
- 0 funds tracked by Wall St. Rank held BIO-key International as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.